Clinical Trials Browser

Diffuse Intrinsic Pontine Glioma

NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003456 2018-03-22

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Phase 2 Completed

40 enrolled 6 charts

CNS

Glioblastoma

NCT00003471 2018-03-22

Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma

Phase 2 Terminated

7 enrolled 6 charts

CNS

Astrocytoma, Recurrence

NCT00003474 2018-03-22

Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme

Phase 2 Completed

40 enrolled 6 charts

CNS

Glioblastoma

NCT00003472 2018-03-21

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Phase 2 Terminated

13 enrolled 6 charts

CNS

Oligodendroglioma, Recurrence

NCT00003535 2018-03-21

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Phase 2 Terminated

9 enrolled 6 charts

CNS

Astrocytoma, Glioma

NCT00003513 2017-09-28

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

Phase 2 Terminated

3 enrolled

CNS

Neuroblastoma

NCT00003470 2017-08-24

AA

Phase 2 Completed

27 enrolled 6 charts

CNS

Astrocytoma

NCT00003475 2017-08-24

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Phase 2 Completed

40 enrolled 6 charts

CNS

Astrocytoma, Glioblastoma

NCT00003476 2017-08-24

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Phase 2 Terminated

8 enrolled 6 charts

CNS

Astrocytoma

NCT00003483 2017-08-24

Antineoplaston Therapy in Treating Patients With Meningioma

Phase 2 Terminated

3 enrolled 6 charts

CNS

Meningioma

NCT00003537 2017-08-24

AA

Phase 2 Completed

19 enrolled 6 charts

CNS

Astrocytoma, Brain Neoplasms

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Phase 2 Completed

40 enrolled 6 charts

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

NCT01260103 2017-07-26

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

Phase 3 Withdrawn

CNS

Recurrence, Optic Nerve Glioma

NCT02988726 2017-07-26

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

Phase 2 Terminated

3 enrolled

CNS

Neurilemmoma, Neurofibroma, Central Nervous System Neoplasms

Clinical Trials

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Antineoplaston Therapy in Treating Children With Brain Tumors

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma

Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

AA

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Antineoplaston Therapy in Treating Patients With Meningioma

AA

Antineoplaston Therapy in Treating Patients With Brain Tumors

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma